Why the founder of the shoe brand Toms is pledging $100 million to psychedelic research
A nascent category of mental-health treatments is getting a major cash infusion. Blake Mycoskie, founder of the Los Angeles–based canvas-footwear phenomenon Toms Shoes, has committed to giving $100 million to support psychedelic research and access, Mycoskie told MarketWatch in an exclusive interview. The money will help fund academic institutions investigating psychedelics’ potential to treat anxiety, …
Why the founder of the shoe brand Toms is pledging $100 million to psychedelic research Read More »